Melissa Marie Amorn, MD
Otolaryngology · West Chester
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 9
- 1 carrier
- Office
- 1
- Since medical school
- 20 years
- Graduated 2006
Offices
1 location · Trihealth H LLC · 850 clinicians in this group
Hospitals listed: Bethesda North · Good Samaritan Hospital · Mccullough-Hyde Memorial Hospital. That is not proof they admit you there this week.
Plans that list them
9 plans · 1 carrier
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Amorn’s office at (513) 853-9250 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
| Alignment Health BreathEasy (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Clarity (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Harmony (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
California Medical Board record
Licence A115925 · Delinquent
Licence status: Delinquent · since 2011 · expires 2026-08-31 · Northeastern Ohio Universities College of Medicine.
License renewal fee has not been paid. No practice is permitted.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
School, training and certification
What this clinician told their state board, medical school and everything before it. Only some states publish this, so nothing here means the state does not say, not that there was no training or certification.
Specialty certification
- American Board of Otolaryngology - Otolaryngology
Hospitals they work in
3 hospitals
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Bethesda NorthCincinnati, OHAcute Care Hospital · Voluntary non-profit - Church · Has an emergency department · Birthing-friendlyPart of TriHealth, which runs 3 hospitalsPatients rate it 3 of 5 · 72% would definitely recommend itOverall rating: 3 of 5 starsBetter than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.127, Oct 2024 – Sep 2025Better than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.206, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.368, Oct 2024 – Sep 2025
- Good Samaritan HospitalCincinnati, OHAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of CommonSpirit Health, which runs 145 hospitals in 19 statesPatients rate it 3 of 5 · 71% would definitely recommend itOverall rating: 4 of 5 starsWorse than the national rate — Rate of inpatient admissions for patients receiving outpatient chemotherapy: 13.1 (11 to 15.4) · 600 cases, Jan 2024 – Dec 2024Better than the national rate — Clostridium Difficile (C.Diff): 0.173, Oct 2024 – Sep 2025
- Mccullough-Hyde Memorial HospitalOxford, OHAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of TriHealth, which runs 3 hospitalsPatients rate it 4 of 5 · 78% would definitely recommend itOverall rating: 3 of 5 starsNo measure marked better or worse than the national rate
See every measure and the patient survey for Bethesda North
Behind the star rating — Deaths: 0 better, 7 the same, 1 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 0 better, 7 the same, 2 worse of 9 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.127 | Better | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.206 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.368 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.88 (0 to 1.76) · 2,206 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.82 (0.56 to 1.08) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 167.21 (121.57 to 212.85) · 134 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 1.9 · 191 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 8.9 · 199 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 9.8 · 404 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 10.7 · 717 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 15.4 · 772 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 11.6 · 567 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 4 · 7,695 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.12 (0 to 0.3) · 10,801 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.32 (0.14 to 0.5) · 11,165 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.22 (1.51 to 4.94) · 2,945 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.44 (0.02 to 2.86) · 1,146 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.53 (1.21 to 3.86) · 2,666 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 8.53 (3.35 to 13.71) · 1,066 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.1 (1.83 to 8.37) · 1,114 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 2.43 (1.01 to 3.86) · 516 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.2 (0 to 0.71) · 8,174 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 4.4 · 153 cases | None | Apr 2023 – Mar 2025 |
| MRSA BacteremiaInfections | 0.777 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 0.646 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 1.443 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 15 · 777 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 21.7 · 1,659 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 18.3 · 449 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -11.4 · 852 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 18 · 804 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 18.9 · 1,365 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.4 (3.4 to 8.5) · 38 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 10.5 (7.3 to 14.8) · 38 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 6.4 · 158 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 10.2 · 282 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.6 · 521 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13.4 (10.5 to 17.1) · 2,130 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.9 (0.7 to 1.1) · 751 cases | No different | Jan 2024 – Dec 2024 |
What patients said (1,897 patients answered, 28% of those asked)
| Cleanliness | 3 |
| Nurse communication | 3 |
| Doctor communication | 3 |
| Communication about medicines | 2 |
| Discharge information | 4 |
| Overall hospital rating | 3 |
| Quietness | 3 |
| Recommend hospital | 4 |
| Room was "always" clean | 70% |
| Nurses "always" communicated well | 79% |
| Doctors "always" communicated well | 78% |
| Staff "always" explained | 57% |
| Yes, staff "did" give patients this information | 87% |
| Yes, staff "did" give patients information about help after discharge | 87% |
| Doctors "always" explained things so they could understand | 72% |
| Doctors "always" listened carefully | 77% |
| Doctors "always" treated them with courtesy and respect | 85% |
| Patients who gave a rating of "9" or "10" (high) | 72% |
| Staff "always" explained new medications | 72% |
| Nurses "always" explained things so they could understand | 75% |
| Nurses "always" listened carefully | 77% |
| Nurses "always" treated them with courtesy and respect | 84% |
| "Always" quiet at night | 54% |
| "YES", patients would definitely recommend the hospital | 72% |
| Staff "always" explained possible side effects | 43% |
| Yes, staff "did" give patients information about possible symptoms | 87% |
See every measure and the patient survey for Good Samaritan Hospital
Behind the star rating — Deaths: 1 better, 6 the same, 0 worse of 7 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 2 better, 8 the same, 0 worse of 10 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 13.1 (11 to 15.4) · 600 cases | Worse | Jan 2024 – Dec 2024 |
| Clostridium Difficile (C.Diff)Infections | 0.173 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.18 (0.25 to 2.1) · 1,271 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.88 (0.57 to 1.18) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 156.57 (103.9 to 209.23) · 67 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for COPD patientsComplications and deaths | 9.2 · 92 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 12 · 109 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 9.7 · 270 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 13.3 · 218 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 14.4 · 418 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.6 · 3,460 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.16 (0 to 0.37) · 5,057 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.26 (0.06 to 0.46) · 5,133 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.17 (1.18 to 5.17) · 1,411 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 2.05 (0.52 to 3.57) · 851 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 3.08 (1.62 to 4.54) · 1,345 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 7.24 (1.32 to 13.17) · 851 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 6.99 (3.8 to 10.19) · 834 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.6 (0.14 to 3.06) · 480 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.17 (0 to 0.87) · 3,648 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 4.1 · 93 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.531 | No different | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 1 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 1.301 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 0 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.829 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 14.1 · 175 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 21.4 · 616 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | -4.1 · 94 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -13.7 · 305 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | -8.9 · 243 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 17.6 · 503 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 4.5 (3.5 to 5.8) · 600 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 7.1 · 86 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 21.3 · 296 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 14.2 (11.2 to 17.9) · 2,799 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1 (0.8 to 1.3) · 645 cases | No different | Jan 2024 – Dec 2024 |
What patients said (1,261 patients answered, 22% of those asked)
| Cleanliness | 3 |
| Nurse communication | 3 |
| Doctor communication | 3 |
| Communication about medicines | 2 |
| Discharge information | 4 |
| Overall hospital rating | 3 |
| Quietness | 3 |
| Recommend hospital | 4 |
| Room was "always" clean | 67% |
| Nurses "always" communicated well | 79% |
| Doctors "always" communicated well | 78% |
| Staff "always" explained | 59% |
| Yes, staff "did" give patients this information | 89% |
| Yes, staff "did" give patients information about help after discharge | 89% |
| Doctors "always" explained things so they could understand | 73% |
| Doctors "always" listened carefully | 77% |
| Doctors "always" treated them with courtesy and respect | 84% |
| Patients who gave a rating of "9" or "10" (high) | 72% |
| Staff "always" explained new medications | 73% |
| Nurses "always" explained things so they could understand | 75% |
| Nurses "always" listened carefully | 75% |
| Nurses "always" treated them with courtesy and respect | 86% |
| "Always" quiet at night | 54% |
| "YES", patients would definitely recommend the hospital | 71% |
| Staff "always" explained possible side effects | 45% |
| Yes, staff "did" give patients information about possible symptoms | 88% |
See every measure and the patient survey for Mccullough-Hyde Memorial Hospital
Behind the star rating — Deaths: 0 better, 4 the same, 0 worse of 4 measures. Safety: 0 better, 3 the same, 0 worse of 3 measures. Readmissions: 0 better, 6 the same, 1 worse of 7 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.04 (0 to 2.12) · 94 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.94 (0.45 to 1.43) | No different | Jul 2022 – Jun 2024 |
| Death rate for COPD patientsComplications and deaths | 9 · 33 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 11.6 · 71 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 14.5 · 87 cases | None | Jul 2022 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 4.7 · 450 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.21 (0 to 0.44) · 777 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.27 (0.05 to 0.48) · 754 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.37 (0.78 to 5.97) · 90 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.66 (0 to 3.39) · 35 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.32 (0.59 to 4.05) · 88 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 8.7 (0 to 18.5) · 33 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.14 (0.84 to 9.44) · 34 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.54 (0 to 1.78) · 470 cases | No different | Jul 2022 – Jun 2024 |
| Clostridium Difficile (C.Diff)Infections | 0.848 | No different | Oct 2024 – Sep 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 21.8 · 95 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 1.7 · 79 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | -17.9 · 85 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.9 · 127 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20 · 42 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.4 (9.1 to 16.6) · 439 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.9 (0.6 to 1.3) · 126 cases | No different | Jan 2024 – Dec 2024 |
What patients said (338 patients answered, 25% of those asked)
| Cleanliness | 5 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 4 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 4 |
| Recommend hospital | 5 |
| Room was "always" clean | 85% |
| Nurses "always" communicated well | 83% |
| Doctors "always" communicated well | 79% |
| Staff "always" explained | 69% |
| Yes, staff "did" give patients this information | 90% |
| Yes, staff "did" give patients information about help after discharge | 91% |
| Doctors "always" explained things so they could understand | 73% |
| Doctors "always" listened carefully | 77% |
| Doctors "always" treated them with courtesy and respect | 85% |
| Patients who gave a rating of "9" or "10" (high) | 78% |
| Staff "always" explained new medications | 81% |
| Nurses "always" explained things so they could understand | 79% |
| Nurses "always" listened carefully | 80% |
| Nurses "always" treated them with courtesy and respect | 90% |
| "Always" quiet at night | 68% |
| "YES", patients would definitely recommend the hospital | 78% |
| Staff "always" explained possible side effects | 57% |
| Yes, staff "did" give patients information about possible symptoms | 89% |
Original Medicare doctor bills
$69,353
Medicare paid this office $69,353 for 418 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Short return visit (20+ min) | 209 | $20,467 | $73 |
| New patient visit (45+ min) | 59 | $8,230 | $139 |
| Return visit (30+ min) | 62 | $7,975 | $111 |
| Diagnostic exam of nasal passages using an endoscope | 28 | $5,601 | $170 |
| Diagnostic exam of voice box using a flexible endoscope | 42 | $5,136 | $122 |
See all 9 services
| Short return visit (20+ min) | 209 | $20,467 | $73 |
| New patient visit (45+ min) | 59 | $8,230 | $139 |
| Return visit (30+ min) | 62 | $7,975 | $111 |
| Diagnostic exam of nasal passages using an endoscope | 28 | $5,601 | $170 |
| Diagnostic exam of voice box using a flexible endoscope | 42 | $5,136 | $122 |
| Short return visit | 90 | $4,330 | $43 |
| Removal of impacted ear wax | 91 | $3,613 | $34 |
| New patient visit (30+ min) | 41 | $3,542 | $86 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 12 | $1,339 | $112 |
Procedures year by year
| Procedure | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|
| Removal of impacted ear wax | 156 | 153 | 149 | 116 | 116 | 105 |
| Diagnostic exam of voice box using a flexible endoscope | 56 | 66 | 61 | 61 | 64 | 42 |
| Diagnostic exam of nasal passages using an endoscope | 33 | 16 | 21 | 29 | 43 | 33 |
| Destruction of soft tissue of nasal passages | – | – | 13 | – | – | – |
Times billed to Original Medicare each year. A blank year means fewer than 11 people had it, or none: Medicare does not publish smaller counts. Medicare Advantage patients are not included.
Who their Medicare patients are
418 Original Medicare patients in 2024. Average age 77 · Under 65 5% · 85 and older 18% · Women 59% · Also on Medicaid 11% · Health risk score 1.20. Above the middle of the specialty; the typical otolaryngology clinician is at 1.19.
Conditions among them: High blood pressure 68% · Diabetes 27% · Chronic kidney disease 24% · Coronary heart disease 22% · Depression 21% · Cancer 18% · Atrial fibrillation 18% · Heart failure 12% · Stroke 12% · COPD 10% · Dementia 8%.
The office billed $289,724, Medicare allowed $98,166 and paid $69,353; for 815 services of 38 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 418 | 815 | 77 | 1.20 | $289,724 | $69,353 |
| 2023 | 442 | 1,061 | 75 | 1.14 | $401,896 | $102,770 |
| 2022 | 477 | 1,044 | 75 | 1.08 | $363,300 | $97,864 |
| 2021 | 487 | 1,127 | 75 | 1.31 | $354,024 | $96,124 |
| 2020 | 456 | 1,028 | 74 | 1.26 | $401,740 | $88,614 |
| 2019 | 443 | 1,001 | 75 | 1.37 | $339,355 | $81,838 |
| 2018 | 416 | 1,142 | 75 | 1.37 | $329,544 | $80,181 |
| 2017 | 376 | 1,116 | 76 | 1.50 | $317,762 | $80,546 |
| 2016 | 387 | 1,101 | 75 | 1.56 | $348,841 | $82,504 |
| 2015 | 387 | 1,193 | 74 | 1.44 | $387,518 | $92,570 |
| 2014 | 317 | 1,028 | 76 | 1.48 | $282,282 | $67,685 |
| 2013 | 237 | 768 | 75 | 1.53 | $237,898 | $55,843 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 9 services
| Short return visit (20+ min) | 195 | $22,688 | $82 |
| Return visit (30+ min) | 122 | $17,998 | $114 |
| New patient visit (45+ min) | 76 | $10,769 | $142 |
| Diagnostic exam of voice box using a flexible endoscope | 58 | $8,486 | $133 |
| Diagnostic exam of nasal passages using an endoscope | 32 | $8,347 | $194 |
| Short return visit | 101 | $6,641 | $49 |
| New patient visit (30+ min) | 68 | $6,271 | $92 |
| Removal of impacted ear wax | 92 | $4,828 | $42 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 15 | $1,765 | $118 |
2022: 9 services
| Short return visit (20+ min) | 198 | $20,075 | $77 |
| Return visit (30+ min) | 121 | $17,666 | $114 |
| New patient visit (45+ min) | 97 | $14,587 | $150 |
| Diagnostic exam of voice box using a flexible endoscope | 56 | $7,616 | $125 |
| New patient visit (30+ min) | 81 | $6,999 | $86 |
| Short return visit | 87 | $5,924 | $46 |
| Diagnostic exam of nasal passages using an endoscope | 23 | $5,631 | $194 |
| Removal of impacted ear wax | 99 | $4,419 | $38 |
| Repositioning exercises of head for treatment of dizziness, each day | 12 | $694 | $39 |
2021: 10 services
| Short return visit (20+ min) | 249 | $27,581 | $78 |
| Return visit (30+ min) | 89 | $12,709 | $116 |
| New patient visit (30+ min) | 115 | $10,857 | $94 |
| Diagnostic exam of voice box using a flexible endoscope | 56 | $7,783 | $128 |
| New patient visit (45+ min) | 48 | $7,158 | $149 |
| Short return visit | 102 | $6,596 | $47 |
| Removal of impacted ear wax | 117 | $5,347 | $36 |
| Diagnostic exam of nasal passages using an endoscope | 19 | $4,167 | $198 |
| Destruction of soft tissue of nasal passages | 11 | $2,961 | $228 |
| Repositioning exercises of head for treatment of dizziness, each day | 14 | $834 | $42 |
2020: 10 services
| Short return visit (20+ min) | 192 | $17,500 | $63 |
| New patient visit (30+ min) | 116 | $10,398 | $90 |
| Diagnostic exam of voice box using a flexible endoscope | 61 | $8,098 | $123 |
| Removal of impacted ear wax | 110 | $5,455 | $36 |
| Short return visit | 96 | $5,019 | $40 |
| New patient visit (45+ min) | 33 | $4,568 | $138 |
| Return visit (30+ min) | 37 | $4,557 | $95 |
| Diagnostic exam of nasal passages using an endoscope | 14 | $3,035 | $190 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 14 | $1,707 | $122 |
| New patient visit (15+ min) | 15 | $963 | $64 |
2019: 11 services
| Short return visit (20+ min) | 182 | $18,416 | $67 |
| New patient visit (30+ min) | 100 | $8,810 | $88 |
| Diagnostic exam of nasal passages using an endoscope | 26 | $6,718 | $204 |
| Diagnostic exam of voice box using a flexible endoscope | 49 | $6,456 | $115 |
| Removal of impacted ear wax | 113 | $5,947 | $38 |
| New patient visit (45+ min) | 40 | $5,583 | $140 |
| Return visit (30+ min) | 42 | $4,939 | $101 |
| Short return visit | 100 | $4,762 | $39 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 18 | $2,460 | $123 |
| New patient visit (15+ min) | 17 | $1,125 | $66 |
| Exam of ear using a microscope | 13 | $452 | $25 |
2018: 13 services
| Short return visit (20+ min) | 182 | $17,504 | $62 |
| New patient visit (30+ min) | 104 | $9,023 | $87 |
| Removal of impacted ear wax | 115 | $6,749 | $40 |
| Diagnostic exam of nasal passages using an endoscope | 26 | $6,229 | $208 |
| New patient visit (45+ min) | 47 | $6,118 | $130 |
| Short return visit | 107 | $5,811 | $38 |
| Diagnostic exam of voice box using a flexible endoscope | 49 | $5,699 | $106 |
| Return visit (30+ min) | 29 | $3,172 | $93 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 16 | $1,935 | $121 |
| Exam of ear using a microscope | 37 | $1,678 | $28 |
| Comprehensive hearing and speech recognition test | 38 | $1,289 | $32 |
| New patient visit (15+ min) | 13 | $848 | $65 |
| Test for eardrum and muscle function | 36 | $694 | $18 |
2017: 13 services
| Short return visit (20+ min) | 165 | $17,689 | $64 |
| New patient visit (30+ min) | 101 | $8,734 | $86 |
| Removal of impacted ear wax | 120 | $6,970 | $41 |
| Diagnostic exam of nasal passages using an endoscope | 29 | $6,918 | $203 |
| Diagnostic exam of voice box using a flexible endoscope | 47 | $5,664 | $107 |
| Short return visit | 84 | $4,788 | $39 |
| New patient visit (45+ min) | 31 | $4,552 | $147 |
| Return visit (30+ min) | 40 | $4,225 | $88 |
| Comprehensive hearing and speech recognition test | 54 | $1,755 | $32 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 14 | $1,669 | $119 |
| Exam of ear using a microscope | 30 | $1,342 | $28 |
| New patient visit (15+ min) | 16 | $989 | $62 |
| Test for eardrum and muscle function | 48 | $899 | $19 |
2016: 13 services
| Short return visit (20+ min) | 193 | $17,123 | $60 |
| Diagnostic exam of nasal passages using an endoscope | 36 | $9,824 | $196 |
| New patient visit (30+ min) | 94 | $7,912 | $84 |
| Removal of impacted ear wax | 111 | $7,808 | $40 |
| Diagnostic exam of voice box using a flexible endoscope | 52 | $5,879 | $105 |
| New patient visit (45+ min) | 33 | $4,229 | $128 |
| Return visit (30+ min) | 32 | $3,523 | $93 |
| Short return visit | 72 | $3,492 | $36 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 21 | $2,461 | $117 |
| New patient visit (15+ min) | 19 | $1,211 | $64 |
| Comprehensive hearing and speech recognition test | 33 | $1,104 | $30 |
| Exam of ear using a microscope | 15 | $865 | $27 |
| Test for eardrum and muscle function | 32 | $575 | $17 |
2015: 16 services
| Short return visit (20+ min) | 191 | $18,285 | $59 |
| New patient visit (30+ min) | 104 | $8,910 | $86 |
| Diagnostic exam of nasal passages using an endoscope | 27 | $7,058 | $202 |
| Removal of impacted ear wax | 107 | $6,504 | $39 |
| Diagnostic exam of voice box using a flexible endoscope | 53 | $6,487 | $105 |
| Return visit (30+ min) | 45 | $4,880 | $96 |
| New patient visit (45+ min) | 34 | $4,748 | $140 |
| Short return visit | 91 | $4,439 | $36 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 19 | $2,237 | $118 |
| Removal of impacted cerumen (one or both ears) by physician on same date of service as audiologic function testing | 23 | $1,156 | $46 |
| New patient visit (15+ min) | 18 | $1,083 | $60 |
| Comprehensive hearing and speech recognition test | 29 | $902 | $31 |
| Exam of ear using a microscope | 19 | $866 | $26 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 12 | $750 | $62 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes | 11 | $537 | $34 |
| Test for eardrum and muscle function | 27 | $470 | $17 |
2014: 12 services
| Short return visit (20+ min) | 179 | $19,152 | $61 |
| Removal of impacted ear wax | 115 | $7,949 | $41 |
| New patient visit (30+ min) | 85 | $6,941 | $82 |
| Diagnostic exam of voice box using a flexible endoscope | 36 | $4,591 | $104 |
| Diagnostic exam of nasal passages using an endoscope | 20 | $4,355 | $198 |
| New patient visit (45+ min) | 22 | $3,203 | $146 |
| Return visit (30+ min) | 26 | $2,950 | $89 |
| Short return visit | 49 | $2,708 | $38 |
| Exam of ear using a microscope | 19 | $1,152 | $29 |
| Comprehensive hearing and speech recognition test | 34 | $1,004 | $29 |
| New patient visit (15+ min) | 12 | $735 | $61 |
| Test for eardrum and muscle function | 43 | $712 | $16 |
2013: 14 services
| Short return visit (20+ min) | 104 | $11,626 | $60 |
| New patient visit (30+ min) | 83 | $6,900 | $83 |
| Removal of impacted ear wax | 87 | $4,641 | $41 |
| Diagnostic exam of nasal passages using an endoscope | 21 | $4,525 | $197 |
| Diagnostic exam of voice box using a flexible endoscope | 25 | $4,261 | $107 |
| Short return visit | 46 | $2,071 | $36 |
| Return visit (30+ min) | 20 | $2,009 | $91 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 13 | $1,493 | $115 |
| Initial hospital care with straightforward or low level of medical decision making, per day at least 40 minutes | 11 | $1,021 | $85 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes | 15 | $882 | $33 |
| New patient visit (15+ min) | 17 | $764 | $45 |
| Test for eardrum and muscle function | 35 | $650 | $18 |
| Exam of ear using a microscope | 13 | $483 | $30 |
| Comprehensive hearing and speech recognition test | 11 | $313 | $28 |
Drugs they prescribed that Part D paid
$8,143
Pharmacies billed $8,143 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
281 generic and fewer than 11 brand-name prescriptions · $8,143 in drug cost · 23 antibiotic prescriptions to 21 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Ipratropium | 78 | $2,741 | $35 |
| Azelastine | 40 | $1,246 | $31 |
| Ofloxacin | 32 | $794 | $25 |
| Fluocinolone Acetonide Oil | 11 | $528 | $48 |
| Fluticasone Propionate | 22 | $322 | $15 |
See all 7 drugs
| Ipratropium | 78 | $2,741 | $35 |
| Azelastine | 40 | $1,246 | $31 |
| Ofloxacin | 32 | $794 | $25 |
| Fluocinolone Acetonide Oil | 11 | $528 | $48 |
| Fluticasone Propionate | 22 | $322 | $15 |
| Amoxicillin-Clavulanate Potass | 14 | $119 | $8 |
| Mupirocin | 13 | $69 | $5 |
Year by year
| 2024 | 286 | 128 | None | None | $8,143 |
| 2023 | 263 | 128 | None | None | $9,469 |
| 2022 | 265 | 131 | None | None | $5,733 |
| 2021 | 247 | 120 | None | 7% | $8,100 |
| 2020 | 235 | 108 | None | 11% | $6,714 |
| 2019 | 187 | 98 | None | 12% | $7,593 |
| 2018 | 183 | 96 | 6% (11) | 6% | $5,383 |
| 2017 | 149 | 75 | None | 9% | $7,334 |
| 2016 | 179 | 82 | None | 7% | $4,261 |
| 2015 | 204 | 101 | 6% (12) | 10% | $6,443 |
| 2014 | 207 | 98 | None | 13% | $6,328 |
| 2013 | 122 | 65 | None | None | $3,126 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 6 drugs
| Ipratropium | 62 | $1,978 | $32 |
| Azelastine | 27 | $701 | $26 |
| Ofloxacin | 21 | $665 | $32 |
| Fluticasone Propionate | 17 | $450 | $26 |
| Mupirocin | 16 | $141 | $9 |
| Amoxicillin-Clavulanate Potass | 13 | $123 | $9 |
2022: 8 drugs
| Ipratropium | 46 | $1,437 | $31 |
| Azelastine | 14 | $603 | $43 |
| Ofloxacin | 21 | $449 | $21 |
| Fluticasone Propionate | 21 | $391 | $19 |
| Amoxicillin-Clavulanate Potass | 24 | $204 | $8 |
| Mupirocin | 18 | $173 | $10 |
| Dexamethasone | 11 | $142 | $13 |
| Methylprednisolone | 11 | $121 | $11 |
2021: 7 drugs
| Ipratropium | 41 | $2,449 | $60 |
| Azelastine | 23 | $1,392 | $61 |
| Fluticasone Propionate | 32 | $552 | $17 |
| Ofloxacin | 17 | $442 | $26 |
| Levothyroxine | 14 | $188 | $13 |
| Mupirocin | 13 | $103 | $8 |
| Amoxicillin-Clavulanate Potass | 11 | $78 | $7 |
2020: 7 drugs
| Ipratropium | 37 | $1,767 | $48 |
| Azelastine | 17 | $562 | $33 |
| Ofloxacin | 20 | $424 | $21 |
| Levothyroxine | 18 | $396 | $22 |
| Fluticasone Propionate | 21 | $354 | $17 |
| Amoxicillin-Clavulanate Potass | 27 | $244 | $9 |
| Mupirocin | 12 | $96 | $8 |
2019: 5 drugs
| Ipratropium | 21 | $1,129 | $54 |
| Ofloxacin | 28 | $694 | $25 |
| Azelastine | 11 | $557 | $51 |
| Amoxicillin-Clavulanate Potass | 14 | $186 | $13 |
| Mupirocin | 17 | $120 | $7 |
2018: 4 drugs
| Ofloxacin | 29 | $999 | $34 |
| Ipratropium | 20 | $864 | $43 |
| Fluticasone Propionate | 22 | $403 | $18 |
| Amoxicillin-Clavulanate Potass | 14 | $138 | $10 |
2017: 4 drugs
| Ipratropium | 20 | $871 | $44 |
| Ofloxacin | 11 | $480 | $44 |
| Fluticasone Propionate | 26 | $406 | $16 |
| Amoxicillin-Clavulanate Potass | 13 | $118 | $9 |
2016: 2 drugs
| Ipratropium | 58 | $1,266 | $22 |
| Ofloxacin | 18 | $424 | $24 |
2015: 5 drugs
| Ipratropium | 37 | $1,008 | $27 |
| Ofloxacin | 14 | $948 | $68 |
| Fluticasone Propionate | 25 | $368 | $15 |
| Mupirocin | 20 | $221 | $11 |
| Cephalexin | 12 | $91 | $8 |
2014: 3 drugs
| Ipratropium | 41 | $1,083 | $26 |
| Fluticasone Propionate | 64 | $1,021 | $16 |
| Ofloxacin | 11 | $270 | $25 |
2013: 2 drugs
| Fluticasone Propionate | 40 | $911 | $23 |
| Ipratropium | 14 | $277 | $20 |
Money from drug and device companies
$415 in 2025
| 2025 | 7 | 12 | None | $415 |
| 2024 | 2 | 2 | None | $48 |
| 2020 | 1 | 1 | None | $12 |
| 2019 | 1 | 1 | None | $180 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Stryker | Audion Et Dilation System | $171 | 1 payment
|
| Genzyme | Dupixent | $109 | 5 payments
|
| Regeneron Healthcare Solutions | Dupixent | $35 | 2 payments
|
| Inspire Medical Systems | Inspire | $30 | 1 payment
|
| Smith+Nephew | None | $27 | 1 payment
|
| GlaxoSmithKline | Nucala | $24 | 1 payment
|
See all 12 published payments
| Stryker | Meals · 2025-10-02 | Audion Et Dilation System | $171 |
| GlaxoSmithKline | Meals · 2025-06-03 | Nucala | $24 |
| Regeneron Healthcare Solutions | Meals · 2025-05-22 | Dupixent | $16 |
| Genzyme | Meals · 2025-05-15 | Dupixent | $19 |
| Genzyme | Meals · 2025-04-14 | Dupixent | $30 |
| Smith+Nephew | Meals · 2025-03-19 | None | $27 |
| Genzyme | Meals · 2025-02-25 | Dupixent | $16 |
| Regeneron Healthcare Solutions | Meals · 2025-02-13 | Dupixent | $19 |
| Cochlear Americas | Meals · 2025-02-12 | Cochlear Nucleus Ci632 Cochlear Implant With Slim Modiolar Electrode | $18 |
| Genzyme | Meals · 2025-01-23 | Dupixent | $23 |
| Inspire Medical Systems | Meals · 2025-01-13 | Inspire | $30 |
| Genzyme | Meals · 2025-01-09 | Dupixent | $20 |
See earlier years (2024, 2020, 2019)
2024: $48
| Genzyme | Dupixent | $26 | 1 payment
|
| Regeneron Healthcare Solutions | Dupixent | $22 | 1 payment
|
2020: $12
| DePuy Synthes Sales | Matrixmidface | $12 | 1 payment
|
2019: $180
| Intersect ENT | Propel | $180 | 1 payment
|
Professional record
- NPI
- 1891948048
- Licence
- CA A115925, DC 149547California A115925: Delinquent · expires 2026-08-31
- Group
- Trihealth H LLC
- Gender
- Female
More record details
- Sole proprietor
- No
- Taxonomy
- Otolaryngology (207Y00000X)
- Mailing address
- 8040 Princeton Glendale Rd, West Chester, OH, 45069
- NPI first listed
- 2008-11-01
- NPI last updated
- 2024-10-14
- NPI record certified
- 2024-10-14
This is when the NPI record was last certified, not a medical board exam.
Extra NPI addresses: 20101 Lake Chabot Rd Fl 3, Castro Valley, CA, 94546 · 3687 Mt Diablo Blvd Ste 200, Lafayette, CA, 94549